Preliminary scientific tests indicate conolidine may perhaps inhibit distinct ion channels, minimizing neuronal excitability and restricting agony signals. This mechanism is especially related in neuropathic suffering, where abnormal signaling will cause persistent discomfort. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to soreness per... https://zachb283nvb7.wikiusnews.com/user